Dr. Oscar Ortiz
Bis 2020, Laborleiter, Merck Group
Munich, Deutschland
Werdegang
Berufserfahrung von Oscar Ortiz
Bis heute 2 Jahre und 4 Monate, seit Feb. 2022
Group Lead ATMP Formulation
Coriolis Pharma
1 Jahr und 8 Monate, Juli 2020 - Feb. 2022
Group Leader GMP analytic Services
Coriolis Pharma
Formulation Research and development of (bio)Pharmaceutical dringst and vaccines —Analysis of Subdivisible particles, aggregates and stability studies under a combination of Certified GMP and biosafety S2 conditions.
Responsible of Cell Banking, Molecular Biology and genome editing services. Microorganisms identification under GMP Mycoplasma detection (qPCR) under GMP
CRISPR subject matter expert and genome editing consulting Service Design and Production of customized cell lines
Management and implementation of new technologies for the generation of murine and cellular models Evaluation and Design of gene targeting strategies and troubleshooting Presentation of scientific results at seminars and international congresses Set‐up of active collaborations with other work groups Supervisor of Master and PhD students
Design, development and improvement of new technologies for gene targeting Production and Genetic Engineering of mammalian cells and mice using CRISPR/Cas9 system and TALE‐nucleases
Ausbildung von Oscar Ortiz
5 Jahre und 7 Monate, Jan. 2003 - Juli 2008
PhD in Neurobiology
Complutense University of Madrid and Cajal Institute of Neurobiology
Distinct roles of D1 and D2 dopamine receptors in learning and in the associated synaptic plasticity and their protein-protein interaction with A2a and CB1 receptors
Sprachen
Deutsch
Fließend
Englisch
Fließend
Spanisch
Muttersprache